Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  ANTA PHAR       

 SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Anthera Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on developing and commercializing products to treat autoimmune diseases. The company's primary product candidate, blisibimod, targets elevated levels of B-cell activating factor, or BAFF, which has been associated with a... 
11/04Earnings Release
Surperformance© rating of ANTA PHAR
Trading Rating : Investor Rating :
More about the company
Duration : Period :
ANTA PHAR Technical Analysis Chart | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 5,00 M
EBIT 2014 -35,4 M
Net income 2014 -36,5 M
Debt 2014 -
Yield 2014 -
Sales 2015 6,00 M
EBIT 2015 -41,4 M
Net income 2015 -42,0 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 12,1x
Capi. / Sales 2015 10,1x
Capitalization 60,4 M
More Financials
Latest news on ANTA PHAR
1d ago ANTHERA PHARMACEUTICALS : Results of Operations and Financial Condition, Financi..
2d ago ANTHERA PHARMACEUTICALS : Reports 2014 Second Quarter Financial Results and Oper..
7d ago ANTHERA PHARMACEUTICALS : Announces Acquisition of Sollpura® liprotamase for Exo..
07/22 ELI LILLY : Anthera Pharmaceuticals Acquires a Novel Investigational Pancreatic ..
07/18 ELI LILLY : Anthera Pharmaceuticals Buys Sollpura (liprotamase) for Exocrine Pan..
07/17 ANTHERA PHARMACEUTICALS : Entry into a Material Definitive Agreement, Financial ..
07/14 ANTHERA PHARMACEUTICALS : Announces Acquisition of Sollpura® (liprotamase) for E..
06/25 ANTHERA PHARMACEUTICALS : Appoints Brian R. Mueller to Board of Directors
06/23 ANTHERA PHARMACEUTICALS : Appoints Brian R. Mueller to Board of Directors
06/13 ANTHERA PHARMACEUTICALS : Change in Directors or Principal Officers, Submission ..
06/13 ANTHERA PHARMACEUTICALS : Appoints Dr. Philip Sager to Board of Directors
05/16 ANTHERA PHARMACEUTICALS : Top Gainers Technical Data -- Research on Zix, Textura..
More news
Income Statement Evolution
ANTA PHAR : Income Statement Evolution
More Financials
EPS Revisions
ANTA PHAR : EPS Revisions
More Estimates Revisions
Dynamic quotes